CROC
Unravelling ChemoResistance mechanisms and improving first-line therapeutic strategies in high-grade serous Ovarian Carcinoma using multi-culture patient-derived organoids
| Grant period | 2023-01-01 - 2024-12-31 |
| Funding body | European Union |
| Call number | HORIZON-MSCA-2021-PF-01 |
| Grant number | 101063359 |
| Identifier | G:(EU-Grant)101063359 |